Denton Pharma recalls
Denton Pharma has 4 recalls on record with the FDA and USDA, the earliest in 2020 and the latest reported on 11 Nov 2020. 2 are still ongoing. The most frequent reason is nitrosamine impurity.
Total recalls4since 2020
Last 12 months0reported
Class I00% of total
Ongoing2latest 11 Nov 2020
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 4 100%Class III 0 0%
Why denton pharma is recalled
Product types
By year
Ongoing denton pharma recalls
2 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Metformin Hydrochloride Extended-Release Tablets USP 750 mg recalled | Denton Pharma | Nitrosamine Impurity | Nationwide |
| Drug | CLASS II | Metformin Hydrochloride Extended-Release Tablets, USP 500 mg, a) recalled | Denton Pharma | Nitrosamine Impurity | Nationwide |
All denton pharma recalls, newest first
4 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Metformin Hydrochloride Extended-Release Tablets USP 750 mg recalled | Denton Pharma | Nitrosamine Impurity | Nationwide |
| Drug | CLASS II | Metformin Hydrochloride Extended-Release Tablets, USP 500 mg, a) recalled | Denton Pharma | Nitrosamine Impurity | Nationwide |
| Drug | CLASS II | Ranitidine Tablets, USP 300 mg a) recalled by Denton Pharma | Denton Pharma | Nitrosamine Impurity | Nationwide |
| Drug | CLASS II | Ranitidine Tablets, USP 150 mg , a) recalled by Denton Pharma | Denton Pharma | Nitrosamine Impurity | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.